Arctic Vision, a global ophthalmic company, announced that it has entered into an agreement to acquire the innovative ophthalmic device business of MDCO Technology, a Hangzhou-based ophthalmic medical-device company.
The proposed transaction will bring MDCO's premium intraocular lens (IOL), implantable contact lens (Phakic Lens), and refractive-device platforms into Arctic Vision's global ophthalmic innovation framework. It strengthens Arctic Vision's global ophthalmic business by integrating advanced device engineering and intelligent manufacturing with its existing innovation capabilities.
Han Kun acted as deal counsel on this transaction. The Han Kun team was led by Paula (Yunge) Liu, with support from a diverse legal team comprised of Lei Chen, Liming Yuan, Ying Li, Tao Li and other members of the firm. The Han Kun team was deeply involved in all key stages of the transaction, including legal due diligence on the group companies of both parties, cross-border deal structure design, agreement drafting and commercial negotiations, demonstrating Han Kun's outstanding legal expertise in handling complex transaction in the field of mergers and acquisitions as well as the medical and pharmaceutical industry.
About Arctic Vision
Arctic Vision is a global ophthalmic innovation company headquartered in Shanghai, China, committed to developing and commercializing next-generation ophthalmic therapies in retinal disease, dry eye, and ocular neuroprotection. With global operations spanning Hong Kong and the U.S., Arctic Vision leverages an in-house platform and strategic partnerships to drive innovation from pre-clinical discovery through commercialization.
About MDCO Technology
MDCO Technology Co., Ltd. is an ophthalmic medical-device innovator specializing in intraocular and refractive lens systems, with R&D and manufacturing bases in Hangzhou, China and California, U.S. The Hangzhou site serves as the center for device R&D, manufacturing, operations, and commercial management in China. With nearly two decades of materials-science and precision-molding expertise, MDCO focuses on premium cataract and myopia-correction solutions and is recognized for intelligent manufacturing and surgical-platform innovation.
Han Kun Mergers & Acquisitions
Han Kun enjoys an outstanding reputation and prestige in the field of mergers and acquisitions. For consecutive years, the firm has been ranked as a Tier 1 or leading law firm by renowned legal rating agencies including Chambers and Partners, The Legal 500, ALB, IFLR1000 and Asialaw Profiles. Han Kun represents domestic and international clients across diverse industries in domestic and cross-border equity and asset acquisitions and mergers. It has advised on a large number of landmark and high-profile M&A projects, covering targets such as start-ups in the new economy sector, traditional private enterprises, state-owned enterprises, listed companies in and outside China, and offshore entities. Transaction forms include equity acquisitions, asset acquisitions, leveraged buyouts, tender offers, auction acquisitions and other structures, establishing the firm's strong brand influence in this field. Han Kun provides full-service legal coverage for M&A projects, including designing transaction structures and processes, formulating restructuring plans, drafting transaction documents, participating in commercial negotiations, assisting with project closing, among others.
